Table 3 HRs (95% CIs) for mortality according to serum 25(OH)D concentrations among participants
| Â | Serum 25(OH)D concentrations (nmol/L) | P value | |||
|---|---|---|---|---|---|
 < 25.00 | 25.00–49.99 | 50.00–74.99 |  ≥ 75.00 | ||
All-cause mortality | |||||
 Number of deaths (%) | 72 (29.51) | 448 (25.18) | 521 (21.46) | 407 (17.24) |  |
 Model 1 HR (95% CI) P-value | 1.00 | 0.70 (0.51,0.95) 0.025 | 0.55 (0.41,0.74) < 0.001 | 0.52 (0.37,0.73) < 0.001 |  < 0.001 |
 Model 2 HR (95% CI) P-value | 1.00 | 0.58 (0.41,0.83) 0.003 | 0.41 (0.29,0.58) < 0.001 | 0.37 (0.25,0.54) < 0.001 |  < 0.001 |
 Model 3 HR (95% CI) P-value | 1.00 | 0.63 (0.44,0.92) 0.017 | 0.50 (0.34,0.71) < 0.001 | 0.46 (0.31,0.69) < 0.001 |  < 0.001 |
CVD mortality | |||||
 Number of deaths (%) | 23 (9.43) | 115 (6.46) | 146 (6.01) | 109 (4.62) | 0.003 |
 Model 1 HR (95% CI) P-value | 1.00 | 0.34 (0.20,0.58) < 0.001 | 0.41 (0.24,0.71) 0.001 | 0.63 (0.35,1.13) 0.12 | 0.020 |
 Model 2 HR (95% CI) P-value | 1.00 | 0.35 (0.19,0.63) < 0.001 | 0.38 (0.21,0.68) 0.001 | 0.59 (0.30,1.13) 0.11 | 0.029 |
 Model 3 HR (95% CI) P-value | 1.00 | 0.34 (0.19, 0.61) < 0.001 | 0.40 (0.22,0.74) 0.003 | 0.60 (0.31,1.15) 0.12 |  |
Cancer mortality | |||||
 Number of deaths (%) | 19 (7.79) | 81 (4.55) | 86 (3.54) | 77 (3.26) |  |
 Model 1 HR (95% CI) P-value | 1.00 | 0.97 (0.52,1.81) 0.92 | 0.85 (0.46,1.58) 0.61 | 1.36 (0.70,2.64) 0.40 | 0.015 |
 M odel 2 HR (95% CI) P-value | 1.00 | 0.90 (0.44,1.88) 0.79 | 0.74 (0.36,1.52) 0.42 | 1.17 (0.55,2.49) 0.69 | 0.070 |
 Model 3 HR (95% CI) P-value | 1.00 | 0.87 (0.45,1.70) 0.69 | 0.72 (0.38,1.36) 0.31 | 1.36 (0.67,2.73) 0.40 | 0.004 |